All articles tagged with #glp 1 receptor
A phase 3 trial shows that ecnoglutide, a once-weekly injection for type 2 diabetes, is as effective as dulaglutide in lowering blood sugar and may lead to greater weight loss, with potential benefits for diabetes management and heart health, and is easier to produce.
Semaglutide, a medication used for type 2 diabetes and obesity, has shown potential as a treatment for alcohol dependence. The drug reduced alcohol relapse drinking and overall alcohol intake in rats by more than half. Semaglutide acts on the GLP-1 receptor and is taken in tablet form once a week. Clinical studies are needed to confirm the findings in humans, but the results offer promising insights into potential additional treatment options for alcohol dependence.